Advanced search
Publication Cover
Expert Review of Endocrinology & Metabolism Volume 14, 2019 - Issue 2
Submit an article Journal homepage
249
Views
6
CrossRef citations to date
0
Altmetric
Drug Profile

Fixed-dose combination of ertugliflozin and metformin hydrochloride for the treatment of type 2 diabetes

Juan Pablo FriasDepartment of Clinical Research, National Research Institute, Los Angeles, CA, USACorrespondence[email protected]
View further author information
Pages 75-83 | Received 17 Oct 2018, Accepted 16 Jan 2019, Published online: 06 Feb 2019

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Vasilios G. Athyros, Chrysoula Boutari & Asterios Karagiannis. (2021) Ertugliflozin + metformin as a treatment option for type 2 diabetes. Expert Opinion on Pharmacotherapy 22:16, pages 2105-2111.
Read now

Articles from other publishers (5)

Bo Pang, Lu-Lu Zhang, Bin Li, Feng-Xian Sun & Zhi-Da Wang. (2023) The sodium glucose co-transporter 2 inhibitor ertugliflozin for Alzheimer's disease: Inhibition of brain insulin signaling disruption-induced tau hyperphosphorylation. Physiology & Behavior 263, pages 114134.
Crossref
Manisha Totade & Shilpa A Gaidhane. (2022) Role of Ertugliflozin in the Management of Diabetes Mellitus. Cureus.
Crossref
Ha Eun Choi, Ji Won Lee, Nam Kyung Je & Kyeong Hye Jeong. (2022) Use of SGLT2 inhibitor/metformin fixed dose combination in Korea. Korean Journal of Clinical Pharmacy 32:1, pages 13-19.
Crossref
Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology 199 229 .
Satish K. Garg, Scott Brackett, Trenton Reinicke & Irl B. Hirsch. (2020) New Medications for the Treatment of Diabetes. Diabetes Technology & Therapeutics 22:S1, pages S-149-S-173.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.